"Cardiac and vascular care center as well as a comprehensive vein disease treatment center for treatment of varicose veins and other chronic venous insufficiency problems we treat simple cardiovascular problems to most advanced diseases, we accept a wide panel of insurances including Medicare and Medicaid along with all major private insurances and large panel of small private insurance as well as wide selection of Medicare managed care plans we also see uninsured patients as cash pay in our office our office is open 7:30 am to 5:00 pm all weekdays and our office has comprehensive testing capabilities and well trained and caring staff"

During the past decade, Northwest Houston Heart Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Houston Heart Center" #1 sponsor was "Eli Lilly and Company" with 5 trials, followed by "Pfizer" with 5 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Houston Heart Center" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Houston Heart Center" are "Obesity" (3 trials), "Angina Pectoris" (2 trials), "Atrial Fibrillation" (2 trials), "Cardiovascular Disease" (2 trials) and "Hyperlipidemia" (2 trials). Many other conditions were trialed in "Northwest Houston Heart Center" in a lesser frequency.

Most popular intervention types in "Northwest Houston Heart Center" are "Drug" (17 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Tirzepatide" (4 trials), "Apixaban" (3 trials), "bococizumab (PF-04950615)" (2 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Houston Heart Center" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Northwest Houston Heart Center". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Northwest Houston Heart Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Houston Heart Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".